Sponsor overview

SciClone Pharmaceuticals

Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.

Back to report

Summary

Signal counts

Assets tracked: 2

Watchlist assets: 2

Registry stop assets: 0

Evidence links

Public sources

https://clinicaltrials.gov/study/NCT00756951 | https://clinicaltrials.gov/study/NCT00450749 | https://clinicaltrials.gov/study/NCT01469429 | https://clinicaltrials.gov/study/NCT05357196

Assets

Linked programs

Placebo: Results Not Found Signal (2/5)
PT-112: Timeline Staleness Signal (4/5)